By Niels Erik Hansen, Ph.D. In January, the Department of Health and Human Services’ Office of the Inspector General (OIG) issued a report about hospitals’ use of standalone compounding pharmacies to produce compounded sterile preparations (CSPs). The study was spurred by concerns about the quality of CSPs following the 2012 meningitis outbreak caused by contaminated... Read more

Categories: Automation | Blog | Regulatory | Safety
Tags: Drug Quality and Security Act | Manual Compounding | RIVA | Safety | Sterile Compounding